Skin AgingNCT07025837
The Effects of an LED Face Mask & Neck and Chest Mask On Skin Health
A study testing iRESTORE Illumina LED Face Mask and Neck & Chest Mask in people with Skin Aging and Sun Damaged Skin, run by Freedom Laser, Inc. at 1 site in United States.
Trial summary
This 12-week single-group virtual study evaluates the effects of the iRESTORE Illumina LED Face Mask and Neck \& Chest Mask on skin health in adult females. Participants will use the devices daily for 10 minutes and complete scheduled surveys and photographs to assess improvements in skin appearance via both… Read more about this study
- Who is it for?
- Ages 25 to 55 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Skin Aging, Sun Damaged Skin
- What is being tested?
- iRESTORE Illumina LED Face Mask and Neck & Chest Mask
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 38 participants
- Where
- 1 siteUnited States
- Study dates
- 14 Oct 2024to 5 Feb 2025
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 55 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Female
- Aged 25-55 years.
- Willing to follow the study protocols.
- Self-reported issues with at least two of the following: Fine lines, Wrinkles, Hyperpigmentation, Dark spots, Reduced elasticity
- Self-report concerns with at least one of the following: Crepey skin on the neck and chest, Sun damage on neck and chest
- Willing to avoid introducing any new products, prescription medications, or supplements that target skin health during the study period.
Show all 12Show fewer
- If taking oral supplements or herbal remedies targeted at skin health and appearance, have been consistently taking these for at least 3 months prior to starting the study.
- Is willing to maintain the routine of any oral supplements or herbal remedies targeted at skin health and appearance for the duration of the study.
- Has been using the same skincare routine for at least one month prior to the study start date.
- Willing to maintain the same skincare routine and products throughout the study.
- Willing to avoid direct sun exposure during the study duration
- Willing to wear sunscreen if have to be in the sun
Who cannot join
- Anyone who is extremely satisfied with their skin.
- Anyone who has any chronic health conditions such as oncological (cancer) or psychiatric disorders.
- Anyone who is planning to undergo facial treatments during the study period, including botox, dermal filler, chemical peels, etc. or has experienced any of these treatments in the last 3 months.
- Anyone diagnosed with a skin condition affecting the face and/or neck who has had an active flare-up or breakout within the last year. This includes but is not limited to acne, eczema, psoriasis, rosacea, seborrheic dermatitis, vitiligo, urticaria (hives), warts, atopic dermatitis, melasma, and contact dermatitis.
- Currently using any prescription medications that may affect the skin condition including but not limited to the following:
- Corticosteroids like prednisone, methylprednisolone
Show all 38Show fewer
- Antipsychotics like olanzapine (Zyprexa), risperidone (Risperdal), quetiapine (Seroquel)
- SSRIs and SNRIs like fluoxetine (Prozac), sertraline (Zoloft), venlafaxine (Effexor)
- Anticonvulsants like phenytoin (Dilantin), lamotrigine (Lamictal), and carbamazepine (Tegretol)
- Antihypertensives like lisinopril (Zestril), amlodipine (Norvasc), and propranolol (Inderal)
- Antithyroid medications like Tapazole (methimazole), Propyl-Thyracil (propylthiouracil)
- Anyone with a history of skin cancer or precancerous skin lesions on the face.
- Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.
- Anyone who has any known allergies to ingredients commonly found in skincare products.
- Anyone who is pregnant, breastfeeding, or trying to conceive
- Anyone who cannot/will not commit to the study protocol.
- Anyone with a history of substance abuse.
- Anyone who has undergone an invasive medical procedure in the three weeks prior to the study or has a procedure planned during the study duration.
- Anyone with a known allergic reaction to aluminum or plastics.
- Anyone who suffers from any photosensitive disorder (sensitization to light).
- Anyone with uncontrolled acne.
- Anyone taking any prescription medication, over-the-counter supplements, or herbal supplements regularly (three or more days per week) that can cause photosensitivity including but not limited to the following:
- Antibiotics like tetracyclines (e.g., doxycycline, tetracycline) or sulfonamides (e.g., Bactrim), fluoroquinolones (e.g., ciprofloxacin, levofloxacin)
- Antifungals like Griseofulvin or Vfend (voriconazole)
- Diuretics like drugs ending in -thiazides
- NSAIDs like ibuprofen and Aleve (naproxen)
- Retinoids or Vitamin A (e.g., Accutane (isotretinoin), (Retin-A) tretinoin
- Antidepressants (e.g., SSRIs, Elavil (amitriptyline), Tofranil (imipramine)
- Antihistamines like Phenergan (promethazine)
- Antimalarial medications
- Statins like Lipitor (atorvastatin), Zocor (simvastatin)
- Antiarrhythmics like Pacerone (amiodarone)
- St. John's wort
- Anyone who suffers from light-induced headaches or migraines.
- Anyone with a medical history of seizures or epilepsy triggered by light.
- Anyone with an electronic implanted device such as a defibrillator, neurostimulator, pacemaker, or ECG monitor.
- Anyone with a known history of carotid artery disease, stroke or transient ischemic attack (TIA), carotid stenosis, unstable blood pressure, easy fainting, thyroid disease, or of individuals about to undergo surgical procedures in the neck area.
- Anyone who has stopped hormonal birth control in the past month.
Trial locations and contacts
1 site in 1 country.
About this study
This 12-week single-group virtual study evaluates the effects of the iRESTORE Illumina LED Face Mask and Neck \& Chest Mask on skin health in adult females. Participants will use the devices daily for 10 minutes and complete scheduled surveys and photographs to assess improvements in skin appearance via both dermatologist assessment and participant perception.
- Conditions
- Skin Aging, Sun Damaged Skin
- Being tested
- iRESTORE Illumina LED Face Mask and Neck & Chest Mask
- Keywords
- Skin Health, Neck and Chest Mask
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
iRESTORE Illumina LED Face Mask and Neck & Chest MaskDevice
A pair of light-emitting diode (LED) therapy devices designed for at-home use. The facial and neck/chest masks deliver low-level red light therapy through embedded LEDs to improve visible signs of skin aging.
| Study group | Role | What they receive |
|---|---|---|
| iRESTORE Illumina LED Device Group | Experimental | All participants will use the iRESTORE LED Face Mask and Neck \& Chest Mask daily for 10 minutes each night. For the face mask, Mode 1 will be used. Receives: Device: iRESTORE Illumina LED Face Mask and Neck & Chest Mask |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of Participants Reported as Having an Improvement in Overall Skin Health as Evaluated by Dermatologist Grading
Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in overall skin health.
Measured: Baseline, Week 12
Percentage of Participants Reported as Having an Improvement in Fine Lines and Wrinkles as Evaluated by Dermatologist Grading
Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in fine lines and wrinkles.
Measured: Baseline, Week 12
Percentage of Participants Reported as Having an Improvement in Skin Pigmentation as Evaluated by Dermatologist Grading
Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in skin pigmentation.
Measured: Baseline, Week 12
Percentage of Participants Reported as Having an Improvement in Skin Redness as Evaluated by Dermatologist Grading
Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in skin redness.
Measured: Baseline, Week 12.
Percentage of Participants Reported as Having an Improvement in Signs of Aging as Evaluated by Dermatologist Grading.
Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in signs of aging.
Measured: Baseline, Week 12
Secondary outcomes (18)
Self-Reported Improvement in Overall Skin Hydration
This outcome measures the change in participant-reported scores for overall skin hydration from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale for skin hydration, including Extremely Dry (=1), Mildly Dry (=2), Neither dry nor hydrated (=3), Hydrated with room for improvement (=4), and Optimally hydrated (=5). Higher scores indicate greater improvement. This is a positively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Skin Plumpness
This outcome measures the change in participant-reported scores for skin plumpness from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of plumpness, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Skin Tone
This outcome measures the change in participant-reported scores for skin tone from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale for skin tone, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Skin Texture
This outcome measures the change in participant-reported scores for skin texture from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of skin texture, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Facial Skin Glow
This outcome measures the change in participant-reported scores for facial skin glow from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of facial skin glow, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Facial Skin Health
This outcome measures the change in participant-reported scores for facial skin health from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of facial skin health, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Facial Skin Appearance
This outcome measures the change in participant-reported scores for facial skin appearance from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of facial skin appearance, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Skin Tone Evenness.
This outcome measures the change in participant-reported scores for skin tone evenness from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of skin tone evenness, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Facial Skin Clarity
This outcome measures the change in participant-reported scores for facial skin clarity from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of facial skin clarity, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Lift and Firmness of Skin
This outcome measures the change in participant-reported scores for lift and firmness of skin from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of skin lift and firmness, including Not at all (=1), A little bit (=2), Somewhat (=3), Very much (=4), and Extremely (=5). Higher scores indicate greater improvement. This is a positively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Severity of Skin Redness
This outcome measures the change in participant-reported scores for severity of skin redness from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of skin redness severity, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Severity of 'Crepey' Skin on the Neck & Chest
This outcome measures the change in participant-reported scores for the severity of 'crepey' skin on the neck \& chest from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of 'crepey' skin severity, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Severity of Dark Spots on the Skin of the Neck and Chest
This outcome measures the change in participant-reported scores for the severity of dark spots on the skin of the neck and chest from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of dark spot severity, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Visibility of Fine Lines and Wrinkles on the Skin of the Neck and Chest.
This outcome measures the change in participant-reported scores for the visibility of fine lines and wrinkles on the skin of the neck and chest from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of fine line and wrinkle visibility, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Severity of Sagging on the Neck
This outcome measures the change in participant-reported scores for the severity of sagging on the neck from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of sagging severity, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Severity of Hyperpigmentation
This outcome measures the change in participant-reported scores for the severity of hyperpigmentation from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of hyperpigmentation, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Visibility of Facial Scars or Blemishes
This outcome measures the change in participant-reported scores for the visibility of facial scars or blemishes from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of scar or blemish visibility, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Visibility of Any Fine Lines and Wrinkles
This outcome measures the change in participant-reported scores for the visibility of any fine lines and wrinkles from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of fine line and wrinkle visibility, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jun 2025
- Study start14 Oct 2024
- Primary completion5 Feb 2025
- Study completion5 Feb 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Skin AgingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 38 participants (actual)
Sponsor and investigators
- Lead sponsor
- Freedom Laser, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07025837
- Sponsor's protocol ID
- 20679
- Status last verified
- Sep 2025
- First submitted
- 10 Jun 2025
- Last updated
- 14 Oct 2025
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effects of an LED Face Mask & Neck and Chest Mask On Skin Health
- ClinicalTrials.gov ID
- NCT07025837
- Acronym / sponsor ID
- 20679
- Conditions
- Skin Aging, Sun Damaged Skin
- Keywords
- Skin Health, Neck and Chest Mask
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 38 participants (actual)
- Lead sponsor
- Freedom Laser, Inc.Industry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Study start
- 14 Oct 2024 (actual)
- Primary completion
- 5 Feb 2025 (actual)
- Study completion
- 5 Feb 2025 (actual)
- First posted
- 18 Jun 2025 (actual)
- Results
- Posted 14 Oct 2025
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This 12-week single-group virtual study evaluates the effects of the iRESTORE Illumina LED Face Mask and Neck \& Chest Mask on skin health in adult females. Participants will use the devices daily for 10 minutes and complete scheduled surveys and photographs to assess improvements in skin appearance via both dermatologist assessment and participant perception.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| iRESTORE Illumina LED Device Group | Experimental | Device: iRESTORE Illumina LED Face Mask and Neck & Chest MaskAll participants will use the iRESTORE LED Face Mask and Neck \& Chest Mask daily for 10 minutes each night. For the face mask, Mode 1 will be used. |
Who may qualify
- Ages
- 25 to 55 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (12 listed)
- Female
- Aged 25-55 years.
- Willing to follow the study protocols.
- Self-reported issues with at least two of the following: Fine lines, Wrinkles, Hyperpigmentation, Dark spots, Reduced elasticity
- Self-report concerns with at least one of the following: Crepey skin on the neck and chest, Sun damage on neck and chest
Key exclusion criteria (38 listed)
- Anyone who is extremely satisfied with their skin.
- Anyone who has any chronic health conditions such as oncological (cancer) or psychiatric disorders.
- Anyone who is planning to undergo facial treatments during the study period, including botox, dermal filler, chemical peels, etc. or has experienced any of these treatments in the last 3 months.
- Anyone diagnosed with a skin condition affecting the face and/or neck who has had an active flare-up or breakout within the last year. This includes but is not limited to acne, eczema, psoriasis, rosacea, seborrheic dermatitis, vitiligo, urticaria (hives), warts, atopic dermatitis, melasma, and contact dermatitis.
- Currently using any prescription medications that may affect the skin condition including but not limited to the following:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| iRESTORE Illumina LED Face Mask and Neck & Chest MaskA pair of light-emitting diode (LED) therapy devices designed for at-home use. The facial and neck/chest masks deliver low-level red light therapy through embedded LEDs to improve visible signs of skin aging. | Device | iRESTORE Illumina LED Device Group |
Primary outcome
Percentage of Participants Reported as Having an Improvement in Overall Skin Health as Evaluated by Dermatologist Grading
Time frame: Baseline, Week 12
Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in overall skin health.
Percentage of Participants Reported as Having an Improvement in Fine Lines and Wrinkles as Evaluated by Dermatologist Grading
Time frame: Baseline, Week 12
Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in fine lines and wrinkles.
Percentage of Participants Reported as Having an Improvement in Skin Pigmentation as Evaluated by Dermatologist Grading
Time frame: Baseline, Week 12
Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in skin pigmentation.
Percentage of Participants Reported as Having an Improvement in Skin Redness as Evaluated by Dermatologist Grading
Time frame: Baseline, Week 12.
Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in skin redness.
Percentage of Participants Reported as Having an Improvement in Signs of Aging as Evaluated by Dermatologist Grading.
Time frame: Baseline, Week 12
Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in signs of aging.
18 secondary outcomes
Self-Reported Improvement in Overall Skin Hydration
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Skin Plumpness
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Skin Tone
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Skin Texture
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Facial Skin Glow
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Facial Skin Health
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Facial Skin Appearance
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Skin Tone Evenness.
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Facial Skin Clarity
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in Lift and Firmness of Skin
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Severity of Skin Redness
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Severity of 'Crepey' Skin on the Neck & Chest
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Severity of Dark Spots on the Skin of the Neck and Chest
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Visibility of Fine Lines and Wrinkles on the Skin of the Neck and Chest.
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Severity of Sagging on the Neck
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Severity of Hyperpigmentation
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Visibility of Facial Scars or Blemishes
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Self-Reported Improvement in the Visibility of Any Fine Lines and Wrinkles
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Oct 2025.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Skin Aging
RecruitingObservational study
Improved Facial Skin Quality and Quality of Life After VYC-12L Treatment in Breast Cancer Survivors
Quality of Life, Breast Neoplasms
Active, not recruiting
Integrated Actionable Aging Assessment for Cancer Patients Pilot
Breast Cancer, Hodgkin Lymphoma
Not yet recruitingObservational study
Clinical Research on Deep-Plane Rejuran S Injection for Improvement in the Apperance of Periorbital Hollowing Using a Cannula Technique
Periorbital Hollowing, Skin Aging
Not yet recruitingObservational study
Clinical Evaluation of Dual-Plane Technique PN-Based Treatment for Horizontal Neck Lines Using DNA Fragment Opmizing Technology Polynucleotide (DOT PN)
Skin Aging, Horizontal Neck Lines
Recruiting
Ultraformer MPT Combined With Fractional CO2 Versus Fractional CO2 Alone for Facial Rejuvenation
Skin Aging
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing iRESTORE Illumina LED Face Mask and Neck & Chest Mask in people with Skin Aging and Sun Damaged Skin, run by Freedom Laser, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 12 inclusion and 38 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 14 Oct 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of Participants Reported as Having an Improvement in Overall Skin Health as Evaluated by Dermatologist Grading (time frame: Baseline, Week 12). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2025.